Response to “Treatment Exposure and the 48-Month Threshold in Prepregnancy Dopamine Agonist Therapy for Prolactinoma”
- 17 July 2026
- journal article
- Published by Elsevier in Endocrine Practice
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Treatment Exposure and the 48-Month Threshold in Prepregnancy Dopamine Agonist Therapy for ProlactinomaEndocrine Practice, 2026
- Prepregnancy Dopamine Agonist Treatment Duration as a Predictor of Postpartum Prolactinoma RemissionEndocrine Practice, 2026
- A simulation study of the number of events per variable in logistic regression analysisJournal of Clinical Epidemiology, 1996
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI: Journal of the National Cancer Institute, 1994